Introduction
How Mounjaro Mechanism of Action addresses the
pathophysiology of obesity and its place within obesity treatment pathways, in alignment with the latest EASO Framework.
Objectives
• To equip healthcare providers with essential knowledge of Mounjaro, efficacy, safety (from SURMOUNT) & emphasizing on Mounajro’s unique Mechanism of Action differentiation to address the complex pathophysiology of obesity, and its place within obesity treatment pathways, in alignment with the latest EASO Framework.
This Course For :
Physician
( Cardiology , Endocrinology & Metabolism , Family Medicine , Orthopedic Surgery , General practitioner )
Resident / Fellow
( Cardiology , Endocrinology & Metabolism , Family Medicine , Orthopedic Surgery , General practitioner )
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
28 Jan 2026 To 28 Jan 2026 -
08:30 PM To 09:30 PM 
Certificate Available 
Online
Add to Calendar
01/28/2026 08:30 PM
01/28/2026 09:30 PM
Asia/ Riyadh
GIP + GLP-1 RA: The Dual Mechanism of Action and the Pathophysiology of Obesity
GIP + GLP-1 RA: The Dual Mechanism of Action and the Pathophysiology of Obesity
https://medicalacademy.org/portal/event/view/2524
